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Ischemic heart disease is a common condition and a leading cause of mortality and
morbidity. Macrophages, besides their role in host defense and tissue homeostasis, are
critical players in the pathophysiological processes induced by myocardial infarction. In
this article we will summarize the current understanding of the role of monocytes and
macrophages in myocardial damage and cardiac remodeling in relation to their origin and
developmental paths. Furthermore, we describe their potential implications in therapeutic
strategies to modulate myocardial healing and regeneration.
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Introduction
Cardiac diseases, especially acute myocardial infarction and congestive heart failure, are among the
most frequent causes of death in the western world and are on the uprise in developing countries.
Even though the survival after myocardial infarction has significantly improved by early revascular-
ization therapy and drug treatment, a significant number of patients develop heart failure. A broad
spectrum of local and systemic mechanisms are initiated in myocardial infarction and contribute
to cardiac remodeling. If uncontrolled, they may lead to negative changes in the geometry, struc-
ture and function of the ventricle and thus may have deleterious effects on cardiac function in the
long term. Therefore, great interest lies in the discovery of new therapeutic strategies to treat the
conditions, which precede heart failure.
In myocardial infarction, occlusion of a coronary vessel (i.e., after coronary artery plaque rup-
ture) results in acutely diminished oxygen supply to the myocardium, which leads to myocyte
necrosis and acute inflammation. As the human heart has only limited regeneration capacity
(Bergmann et al., 2009), infarct healing is–in addition to restoration of oxygen supply–very much
dependent on the inflammatory response. Macrophages are an integral part of the innate immune
response. They are equipped with an array of pathogen recognition receptors which can activate
phagocytosis of pathogens and the secretion of cytokines and chemokines. They present antigens
on their cell surface by constitutively expressed major histocompatibility complex II (MHC II) and
thereby interact closely with the adaptive immune system.
In vertebrates, macrophages are found in all organs, where they adopt distinct phenotypes and
functions that are shaped by the environment of the organ of residence (Gosselin et al., 2014; Lavin
et al., 2014). Macrophages are also found in larger numbers in the mammalian heart (Jung et al.,
2000; Epelman et al., 2014a; Heidt et al., 2014; Molawi et al., 2014).
Macrophages have long been thought to be of importance in cardiac remodeling after myocar-
dial infarction in humans (Mallory et al., 1939). In autopsy reports macrophage numbers associated
closely with different stages of myocardial infarction (Chang et al., 2013). Likewise, macrophages
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play a critical role in experimental infarction models including
rodents (Yang et al., 2002) and swine (Vilahur et al., 2011). In
this review we will summarize the functions of monocytes and
macrophages in myocardial infarction and outline potential ther-
apeutic strategies to improve infarct healing and outcome by
manipulating distinct subsets of mononuclear phagocytes.
Recruitment of Monocytes Into the
Ischemic Heart
The immune response to myocardial ischemia can be divided
into distinct but overlapping inflammatory phases, in a simplified
view an early (3–4 days) and a late (7–10 days) phase. The kinetics
are dependent on the pathological conditions and respective dis-
ease models (e.g., species analyzed, chronic ligation vs. ischemia
and reperfusion model). Within 30min after induction of infarc-
tion through ligation of the left anterior descending artery (LAD),
monocytes are recruited to the site of injury as shown by in vivo
microscopy (Jung et al., 2013; Nahrendorf and Swirski, 2013).
However, the applied reporter mice did not permit distinguishing
between the monocyte subsets involved. In mice, blood mono-
cytes are divided into two principal subsets: Ly6Chi CCR2+
CX3CR1lo “inflammatory” monocytes (CD14+ in humans) and
a less frequent subset of Ly6Clo CCR2− CX3CR1hi monocytes
(CD14dim CD16+ in humans). Ly6Clo monocyte “patrol” the
luminal side of the endothelium of small blood vessels under
homeostatic and inflammatory conditions (Auffray et al., 2007).
Initial work suggested that the early phase after infarction is
dominated by inflammatory (Ly6Chi) monocytes (Nahrendorf
et al., 2007). They phagocytose toxic molecules and cell debris,
have proteolytic activity and produce inflammatory cytokines like
interleukin (IL)-1α, IL-6 and TNFα (Nahrendorf et al., 2007;
Troidl et al., 2009; Woollard and Geissmann, 2010; Leuschner
et al., 2012). Thus, by exercising inflammatory functions they are
potentially harmful in this early phase and promote myocardial
damage (Kaikita et al., 2004). In contrast to Ly6Chi monocytes,
non-classical Ly6Clo monocytes were thought to play a role in
the later stages after infarction (Nahrendorf et al., 2007). Through
secretion of anti-inflammatory cytokines and growth factors, like
VEGF and TGF-ß, they could promote angiogenesis, extracellu-
lar matrix synthesis and myocardial healing (Nahrendorf et al.,
2007; Troidl et al., 2009). However, the clear categorization of
monocyte subsets into distinct phases and functions after infarc-
tion has recently been challenged. Ly6Clo monocytes are critically
dependent on the transcription factor Nr4a1 for their develop-
ment and survival (Hanna et al., 2011). Interestingly, absence of
Ly6Clo monocytes in Nr4a1-deficient animals does not abrogate
the bi-phasic inflammatory response. These findings might be
explained by the concept that Ly6Clo cells derive from Ly6Chi
monocytes, which display high plasticity and develop into either
proinflammatory or anti-inflammatory monocytes/macrophages
(Hilgendorf et al., 2014; Ismahil et al., 2014). The transcription
factor Nr4a1 thereby seems to serve as a master switch that con-
trols the polarity of monocytes and could represent a poten-
tial target to modulate the local inflammatory response, which
drives adverse cardiac remodeling. The findings also indicate that
inflammatory Ly6Chi monocytes are the predominant monocyte
subset to be recruited to the infarct area not only in the first days
of infarction but throughout the course of post-infarct remod-
eling (Nahrendorf et al., 2010; Hilgendorf et al., 2014; Ismahil
et al., 2014). This is supported by data in humans demonstrat-
ing that peak levels of the corresponding subset of inflammatory
(CD14+) monocytes correlate negatively with the recovery of left
ventricular function after acute myocardial infarction (Tsujioka
et al., 2009). In mice, inhibition of Ly6Chi inflammatory mono-
cyte recruitment into the infarcted myocardium by genetic abla-
tion of C-C chemokine receptor type 2 (CCR2) reduced adverse
cardiac remodeling (Kaikita et al., 2004).
Future studies are needed to clearly define the role and impact
of monocyte subsets in the course of infarction. In any case, pre-
clinical (Panizzi et al., 2010) and clinical data (Tsujioka et al.,
2009; Aoki et al., 2011) indicate that monocyte/macrophage
recruitment needs to be tightly controlled as dysregulated infil-
tration results in infarct expansion, left ventricular dilation, and
heart failure. In detail, monocytosis disturbs resolution of inflam-
mation in murine infarcts and consequently enhances left ven-
tricular remodeling (Panizzi et al., 2010). This is associated with
the extent of myocardial salvage and the recovery of left ventric-
ular function after acute infarction (Tsujioka et al., 2009).
As a side note, neutrophils accumulate in larger numbers
during the early phase of ischemic injury, but disappear within
approximately 24 h whereas the monocyte/macrophage response
is sustained (Jung et al., 2013; Nahrendorf and Swirski, 2013). In
addition to the recruitment of blood derived monocytes, tissue-
resident macrophages in the heart represent another source of
innate immune cells, which likely contribute to a local inflam-
matory process in the ischemic myocardium (Epelman et al.,
2014a).
Origin of Resident Cardiac Macrophages
The formerly believed rational, that blood-derivedmonocytes are
the only source of macrophages in the heart, has been challenged
by recent work establishing the yolk sac as a common source of
macrophages in adult tissues (Ginhoux et al., 2010; Schulz et al.,
2012; Gomez Perdiguero et al., 2015). In line with these find-
ings, also cardiac macrophages have their origin, at least to some
extent, in the yolk sac (YS). Tamoxifen-induced pulse-labeling of
Csf1r+ YS macrophages between embryonic days E8.5 and E9.5,
when definitive hematopoiesis is not yet present, labeled a pro-
portion of resident macrophages in the adult mouse heart (Epel-
man et al., 2014a; Molawi et al., 2014) (Figure 1A). These initial
fate-mapping strategies were useful to assess the qualitative con-
tribution of YS progenitors to adult tissue macrophages (Schulz
et al., 2012; Epelman et al., 2014b). More recent work assessed
the quantitative potential of YS progenitors for tissue resident
macrophages in vivo, and established the YS as the key source
of macrophages in adult tissues (Gomez Perdiguero et al., 2015).
While YS-derivedmacrophages initially display a common signa-
ture (Schulz et al., 2012), their distinct phenotype and function is
later shaped by local environmental cues specific for the respec-
tive tissue of residence (Gosselin et al., 2014; Lavin et al., 2014).
Tissue macrophages perform specific duties, such as homeostatic
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FIGURE 1 | Fate mapping analysis of cardiac macrophages.
(A) Frozen tissue sections of 1 year old mouse. FVB strain Csf1rMeriCreMer
females mated with BL6 ROSA LSL−YFP/LSL−YFP male were pulse labeled
by injection of 75µg/g hydroxytamoxifen on embryonic day 8.5 (E8.5). This
labeling regime allowed the specific labeling of Csf1r+ cells derived from
the yolk sac, as definitive hematopoiesis is not present at that time point. 1
year old mice were stained for F4/80 (red) and YFP (green); double-positive
cells represent yolk-sac derived macrophages. Bars 50µm (Schulz et al.,
2012; Epelman et al., 2014a). (B) Frozen tissue sections of 6 month old
Myb-deficient BM chimera (CD45.1/CD45.2). BM ablation was obtained
through deletion of Myb by injection of poly(I:C) into CD45.2; Mx1-Cre;
Mybflox/flox mice. Whole BM (107 cells) from CD 45.1 mice was
transplanted after BM-ablation as described earlier (Schulz et al., 2012).
The heart was examined 12 weeks after BM transplantation and sections
were stained with DAPI (blue), F4/80 (red) and CD45.2 (green);
double-positive (F4/80 positive, CD45.2 positive) cells represent
host-derived macrophages; (∗) represents a donor-derived macrophage
(F4/80 positive, CD45.2 negative). Bars 20µm.
functions and immune surveillance in other tissues (Davies et al.,
2013). Nevertheless, their role in inflammatory processes in the
heart needs to be determined.
It remains unknown to date, for how long YS-derived
macrophages reside in adult tissues. In many organs, such as
the brain and the liver, these cells are not replaced at steady
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state (Gomez Perdiguero et al., 2015) and can persist indepen-
dently of HSCs (Schulz et al., 2012) (Figure 1B). However, a
specific environment (e.g., intestine) or bacterial infections may
result in replacement of tissue macrophages by bone marrow-
derived monocytes (Bain et al., 2014; Bleriot et al., 2015). In the
intestine, YS-derived macrophages are replaced by bone mar-
row monocytes within the first weeks of life due to substantial
changes of the environment. Interestingly, the number of YS-
derived resident macrophages in the mouse heart also seems
to be impermanent and declines with age. As mice grow older
the proliferation rate of cardiac macrophages decreases and is
probably insufficient to maintain the resident macrophage pool
(Molawi et al., 2014). Likewise, resident macrophages in the
heart are lost as a consequence of myocardial infarction. They
need to be substituted either through monocyte intermediates,
which are recruited from the circulation, or by local proliferation
and expansion of resident cells. Further experimental evidence
is needed to define the quantitative contribution of circulation
monocytes to the cardiac macrophage pool during aging and in
the setting of myocardial injury (Heidt et al., 2014; Lavine et al.,
2014; Molawi et al., 2014). Finally, it is still unknown to what
extent monocyte-derived macrophages are distinct from resident
macrophages with respect to their effector functions in tissues
(Schulz andMassberg, 2014). Undoubtedly, the findings will have
implications for our understanding of cardiac homeostasis and
disease.
Macrophage Subsets in the Heart
Recently, it has become clear that cardiac macrophages consist
of several different subpopulations (Epelman et al., 2014a; Heidt
et al., 2014; Lavine et al., 2014; Molawi et al., 2014). Elaborate
multicolor flow cytometry studies allowed a comprehensive char-
acterization of different macrophage subsets by cell surface mark-
ers including CD11b, F4/80, Cx3Cr1, major histocompatibility
complex II (MHC II), CCR2 and Ly6C.
Accumulating evidence suggests that the composition of
macrophage subsets in the myocardium undergoes dynamic
changes in the course of life. This needs to be kept in mind when
discussing cardiac macrophage populations in the heart, espe-
cially as the macrophage subsets have different regenerative and
inflammatory potential. In newborn mice cardiac macrophages
display a MHC IIlo phenotype and have predominantly origi-
nated from the yolk sac. This subset of macrophages seems to
have distinct, probably beneficial, effects on the myocardium
under stress. As mice age, the macrophage phenotype diversifies
into a MHC IIlo and a MHC IIhi phenotype. Fate mapping anal-
ysis in adult mice using pulse labeling of macrophages indicated
that the contribution of embryo-derived cardiac macrophages to
the MHC IIlo subset was higher than to MHC IIhi macrophages.
Between birth and 30 weeks of age resident macrophages
become increasingly replaced bymonocyte-derivedmacrophages
from the bone marrow (Lavine et al., 2014; Molawi et al.,
2014).
Another surface marker to describe macrophage subsets
is CCR2, the receptor for chemokine monocyte chemoat-
tractant protein-1 (MCP-1/CCL2), which facilitates monocyte
chemotaxis. This marker helps to identity macrophages, which
recently derived from circulating monocytes (Epelman et al.,
2014a; Lavine et al., 2014). Using CCR2 and MHC II, cardiac
monocyte, and macrophage subsets of the neonatal and adult
heart could be defined. In a nutshell, at least two subsets exist
in the neonatal heart at steady state, namely a CCR2−/MHC
IIlo subset derived predominantly from the yolk sac and a
CCR2+/MHC IIlo subset derived from definitive hematopoiesis.
In contrast, in the adult heart (6 weeks of age), the mono-
cyte/macrophage population could be divided into 4 subsets. The
CCR2− population had a diversified phenotype with MHC IIlo
and MHC IIhi macrophage subsets and a mixed developmen-
tal origin. In contrast, the CCR2+ population derived exclu-
sively from definitive hematopoiesis and could be subdivided into
MHC IIhi and MHC IIlo populations (Lavine et al., 2014).
Age-Dependent Response of
Macrophages to Myocardial Stress
Besides the unknown influence of the origin of macrophages on
myocardial repair, it has become clear that macrophages exhibit a
distinct potential to facilitate regeneration during different stages
of life. Subjecting neonatal mice tomyocardial infarction on post-
natal day 1 (P1), the ischemic myocardium has been shown to
completely regenerate by proliferation of preexisting cardiomy-
ocytes. This regeneration capacity is already lost during the first
week after birth. Induction of myocardial infarction 14 days post-
partum (P14) showed left ventricular scarring and cardiomyocyte
hypertrophy comparable to the pathophysiological changes seen
in adult animals after myocardial infarction (Porrello et al., 2013).
Macrophages differed in number, localization, and gene expres-
sion profile in mice subjected to myocardial infarction on P1 and
P14 after birth. Even more strikingly, the regenerative capacity
of the neonatal heart after myocardial infarction was lost when
macrophages were depleted using clodronate liposomes. The
depletion of macrophages in neonates was accompanied by a loss
of neovascularization (Aurora et al., 2014). These results stress
the importance of macrophages in the regeneration potential of
neonatal mice.
In fact, neonatal mice react to myocardial stress (e.g., after
in vivo cardiomyocyte cell ablation) with an expansion of
the MHC IIlo macrophage subpopulation. It could be shown
that these macrophages possess proangiogenic and reparative
properties which, at least partially, contribute to the regenerative
capacity of the neonatal heart. Fate mapping analysis revealed
that this macrophage subset is of yolk sac origin. In contrast,
adult mice respond to myocardial injury with the recruitment
of inflammatory MHC IIhi CCR2+ macrophages from the blood
circulation and loss of potentially beneficial CCR2− (resident)
macrophages. These mice developed pathological left ventricular
remodeling including cardiomyocyte hypertrophy, fibrosis, and
LV dilation resulting in a decreased LV function. Blocking the
recruitment of CCR2+ monocytes into the injured myocardium
preserved cardiac MHC IIlo macrophages in the adult heart
and showed beneficial effects on coronary angiogenesis
and attenuated inflammation (Lavine et al., 2014). This
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FIGURE 2 | Role of different macrophage subtypes in cardiac
remodeling. In steady state, the adult mouse heart contains various types of
macrophage populations, which are of yolk sac (YS) or bone marrow (BM)
origin dependent on the mouse age. CCR2− macrophages are of mixed
origin but predominately derive from YS/embryonic precursors. CCR2+
monocytes and macrophages are derived from the bone marrow. In adult
mice, myocardial stress triggers the depletion of resident cardiac
macrophages followed by the recruitment of “inflammatory” CCR2+
monocytes. Inhibition of CCR2 leads to a decreased recruitment of
CCR2+monocytes into the myocardium and protects resident cardiac
macrophages which has a beneficial impact on coronary angiogenesis,
inflammation and cardiac remodeling (Kaikita et al., 2004; Lavine et al., 2014).
underscores a beneficial role of resident cardiac macrophages
(Figure 2).
It is currently unknown whether the effects of the different
macrophage populations on cardiac remodeling after in vivo car-
diomyocyte cell ablation also apply to the myocardial infarc-
tion model. Intriguingly, myocardial infarction in adult mice is
accompanied by the loss of resident cardiac macrophages. Con-
sequently, blood-derivedmonocytes are recruited to the ischemic
myocardium and repopulate the cardiac resident macrophage
population (Heidt et al., 2014). Further studies are required
to unravel the role of the different macrophage populations in
infarct healing.
Macrophages as Therapeutic Targets for
Myocardial Repair
Monocytes and macrophages play a detrimental role in
the pathophysiological processes triggered by infarction and
therefore represent a potential therapeutic target to promote
myocardial repair and functional regeneration. Yet we have only
begun to understand the spatiotemporal relationships and func-
tions of the different macrophage subsets in the course of infarct
healing. It is likely that cell-type specific therapies as well as ade-
quate timing of respective therapies will be able to achieve a
more beneficial outcome in cardiovascular remodeling. In the
following, we will highlight differential strategies targetingmono-
cytes and macrophages, which have the potential to reduce the
inflammatory burden in the post-infarct myocardium.
One approach that has been investigated for some time is
blocking the recruitment of inflammatory monocytes. This can
be achieved for example by interfering with chemokine gradients
resulting in a reduction of circulating inflammatory monocytes
(e.g., ablation of CCR2), or by inhibition of their recruitment
into the ischemic myocardium (e.g., C-X-C chemokine receptor
type 6 (CXCR6), macrophage migration inhibitory factor MIF).
Reduction of inflammatory CCR2+ monocytes either using a
knockout model of CCR2 or an antibody-mediated approach
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attenuated the inflammatory response aftermyocardial infarction
and had beneficial effects on cardiac remodeling (Kaikita et al.,
2004; Lavine et al., 2014). Likewise, disruption of the CXCL16-
CXCR6 axis in an ischemia/reperfusion model, led to a decreased
number of CD11b+ cells in the infarcted tissue resulting in
improved cardiac function and attenuated cardiac remodeling
through a diminished autophagic response (Zhao et al., 2013).
Inhibition of MIF influences apoptotic pathways and other sig-
naling cascades. Importantly, plasma MIF levels are associated
with infarct size and extent of cardiac remodeling in humans.
However, blockade of MIF is rather unspecific, and among other
effects, also reduces the influx of neutrophils (Gao et al., 2011;
Chan et al., 2013).
Another approach to modulate macrophage function is to
modify their environment. As shown only recently, macrophage
phenotypes and functions are shaped by the microenvironment
of the organ of residence (Gosselin et al., 2014; Lavin et al.,
2014). For example, transplantation of differentiated peritoneal
macrophages into the lung environment induced reprogramming
of the transcriptional landscape of these cells and their acquire-
ment of new tissue specific functions. It is tempting to speculate
that the same is true for the cardiac microenvironment.
Further, resident macrophages also interact with surround-
ing immune cells, including those of the adaptive immune sys-
tem. Regulatory T cells have recently been shown to modulate
monocyte/macrophage differentiation in the setting of myocar-
dial infarction with a positive impact on wound healing and
remodeling (Weirather et al., 2014). Whether enhancement of
regulatory T-cells is beneficial for infarct repair is currently
unknown. In addition, B lymphocytes interact with monocytes
in the course of cardiac repair after myocardial infarction. In
this setting, B cells facilitate mobilization and recruitment of
Ly6Chi monocytes into the ischemic myocardium by secretion
of CCL7. Genetic as well as antibody-induced depletion of B
cells reduced circulatory monocytes and inflammatory Ly6Chi
monocytes in the myocardium which improved cardiac func-
tion and attenuated myocardial injury (Zouggari et al., 2013).
However, the precise mechanisms of the crosstalk between the
adaptive immune system and monocytes/macrophages and its
therapeutic potential in cardiac remodeling will require further
experimental data.
Depletion of macrophages could represent another approach
to modulate myocardial inflammation. However, this approach
is likely to represent a double edged sword. Depletion of by
injection of clodronate liposomes during the first week after
myocardial injury led to reduced removal of necrotic cells,
impaired neovascularization and increased scar formation. This
resulted in a higher mortality of macrophage-depleted mice (van
Amerongen et al., 2007; Ben-Mordechai et al., 2013; Frantz et al.,
2013). Further, clodronate liposomes deplete most phagocytic
cells, including dendritic cells (Leenen et al., 1998) and are there-
fore not specific. Still, phagocytic properties of mononuclear
phagocytes may be harnessed to deliver drugs to their site of
action, as reviewed elsewhere (Ben-Mordechai et al., 2015).
Finally, resident cardiac macrophages might be targeted
through the alteration of intracellular signals, which for exam-
ple induce proliferation or apoptosis. IL-4 has been shown to
directly signal to tissue-resident macrophages and induce their
proliferation above homeostatic levels (Jenkins et al., 2013). Tar-
geting expression of the transcription factor MafB may inhibit
macrophage apoptosis in tissues during inflammatory conditions
(Hamada et al., 2014). Small-interfering RNA could thereby help
achieve robust gene silencing. Delivery of respective particles in
an encapsuled form revealed an efficient uptake by phagocytes
(Aouadi et al., 2009). However, strategies targeting function of
resident macrophages will have to account for their physiological
role in tissue homeostasis (e.g., Nr4a1) in organs, including the
heart (Schulz and Massberg, 2014).
In summary, modulation of macrophage functions repre-
sents an interesting therapeutic strategy. Its success, however,
will depend on a deeper understanding of the heterogene-
ity of macrophage subsets and their developmental origin and
molecular regulation. Further, the regulatory signals derived
from the local microenvironment in the heart at steady state
and in the course of infarction, which modulate the pheno-
type and functional specification of macrophages, require further
investigation.
Concluding Remarks
Despite their abundance in the myocardium, the function of
the different cardiac macrophage populations at steady state
and in response to stress is largely unknown. There is no
doubt that future studies will reveal the precise contribution
of monocyte/macrophage populations to myocardial remodel-
ing in pathological conditions thereby integrating findings on
their developmental origin and regulation. Of note, recent data
in mouse models of infarction suggest that “time” may matter
in various ways. First, monocyte/macrophage populations may
have a distinct role at different stages of myocardial remodel-
ing and thus, targeting these immune cells at specific time points
could further improve wound healing and functional outcome.
Second, it may also play a role at which age experimental models
(e.g., myocardial infarction) are performed, as macrophage pop-
ulations in the heart are –at least in mice– replaced over time
(Molawi et al., 2014) and also the recovery potential abates with
age (Lavine et al., 2014). These recent studies on the heterogeneity
and kinetics of monocytes and macrophage subsets in the mam-
malian heart have paved the way for new therapeutical strategies
to target infarct repair after myocardial infarction. Despite the
recent advancement on our understanding of the pathomecha-
nisms, specifically the kinetics and regulation of inflammatory
processes and wound healing in the diseased heart, early reperfu-
sion therapy for patients who have myocardial infarction remains
the essential basis to preserve myocardial function and reduce
mortality.
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